166 related articles for article (PubMed ID: 12611260)
21. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics.
Iavazzo C; Vorgias G; Katsoulis M; Kalinoglou N; Dertimas V; Akrivos T
Arch Gynecol Obstet; 2008 Jul; 278(1):53-6. PubMed ID: 18488238
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma].
Peng YZ; Shen K; Wu M; Huang HF; Pan LY; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):243-5. PubMed ID: 15924670
[TBL] [Abstract][Full Text] [Related]
23. [Peritoneal papillary serous carcinoma in a patient with previous surgery for breast cancer: clinical case].
Amanti C; Lombardi A; Moscaroli A; Catracchia V; Lo Russo M; Marino G; Conte S; Provenza G
G Chir; 2006; 27(1-2):45-8. PubMed ID: 16608633
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
25. Prolonged symptom-free survival in a patient with persistent primary peritoneal carcinoma and a rising CA-125: a note of caution.
Markman M
Gynecol Oncol; 2001 Jun; 81(3):509-11. PubMed ID: 11371148
[TBL] [Abstract][Full Text] [Related]
26. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma.
Hamilton CA; Liou WS; Osann K; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):839-44. PubMed ID: 16199314
[TBL] [Abstract][Full Text] [Related]
27. Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
Herrada J; Kudelka AP; Tornos C; Shin DM; Kavanagh JJ; Edwards CL; Verschraegen CF
Eur J Gynaecol Oncol; 1997; 18(1):39-41. PubMed ID: 9061321
[TBL] [Abstract][Full Text] [Related]
28. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case].
Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J
Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890
[TBL] [Abstract][Full Text] [Related]
29. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
30. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry.
Alberti N; Serrano-Egea A; García-García E; Ballestín C; Pérez-Barrios A; López-Ríos F; de Agustín P
Acta Cytol; 2007; 51(2):203-6. PubMed ID: 17425204
[TBL] [Abstract][Full Text] [Related]
31. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
Alberts DS; Marth C; Alvarez RD; Johnson G; Bidzinski M; Kardatzke DR; Bradford WZ; Loutit J; Kirn DH; Clouser MC; Markman M;
Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
[TBL] [Abstract][Full Text] [Related]
32. Adverse affects of paclitaxel and carboplatin combination chemotherapy in epithelial gynecologic cancer.
Kietpeerakool C; Suprasert P; Srisomboon J
J Med Assoc Thai; 2005 Mar; 88(3):301-6. PubMed ID: 15962635
[TBL] [Abstract][Full Text] [Related]
33. [Extraovarian peritoneal serous papillary carcinoma: studies of clinical and pathological features].
Shi X; Guo Y; Li J
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):711-3. PubMed ID: 9387509
[TBL] [Abstract][Full Text] [Related]
34. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Pautier P; Lhommé C; Duvillard P; Castaigne D
Gynecol Oncol; 2005 Apr; 97(1):136-41. PubMed ID: 15790449
[TBL] [Abstract][Full Text] [Related]
35. Serous and mesothelial proliferations of the extraovarian peritoneum and pelvic lymph nodes.
Walker AN; Mills SE
Pathology (Phila); 1993; 1(2):411-39. PubMed ID: 9420925
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst.
Papoutsis D; Rodolakis A; Haidopoulos D; Sotiropoulou M; Antsaklis A
Eur J Gynaecol Oncol; 2009; 30(1):103-5. PubMed ID: 19317271
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal papillary serous carcinoma: response to Taxol in platinum resistant disease.
Wilailak S; Kudelka AP; Donner LR; Silva E; Mante R; Kavanagh JJ
Eur J Gynaecol Oncol; 1995; 16(3):187-9. PubMed ID: 7664764
[TBL] [Abstract][Full Text] [Related]
38. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
39. Weekly carboplatin in a frail elderly woman with advanced peritoneal carcinoma.
Piura B; Meirovitz M
Arch Gynecol Obstet; 2005 Dec; 273(3):192-4. PubMed ID: 16001195
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]